In our study, we used BMI as a surrogate marker for obesity and found that EC patients with higher BMI were more likely to have lymph node metastasis, negative ER and PR expression, and deeper LVSI, which commonly predicts poor prognosis of EC. Here, ESR1 is linked to metastatic malignant neoplasm in the lymph nodes.